Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Investigating the role of Gly482Ser single nucleotide polymorphism in hepatocyte function through induced pluripotent stem cells and human samples
FY 2018-19
Summary
Diabetes and nonalcoholic fatty liver disease (NAFLD) are growing metabolic problems in our society today. PGC-1a is a protein expressed in liver cells, and is involved in mitochondrial biogenesis, fatty acid oxidation and increased gluconeogenesis. It is found to be upregulated in mouse models as well as patients with diabetes.
The single nucleotide polymorphism (SNP) Gly482Ser is known to exist on PGC-1a, and we wish to investigate its effect on hepatocyte mitochondrial function. The glycine SNP is “normal” in humans, and the variant serine SNP is found in about 10% of people. I wish to investigate the role of this SNP in hepatocyte metabolic function.
I will be genotyping induced pluripotent stem cells (iPSCs), and using CRISPR technology to create lines of all three genotypes (gly/gly, ser/gly, ser/ser). Then we will differentiate the cells into hepatocyte-like cells, and validate that the cells function like hepatocytes. I will need to optimize this process to ensure the cells have the proper characteristics.
Once I have shown the cells have been correctly differentiated, i will test their mitochondrial function using a Seahorse XF Cell Mito Stress Test Kit. This test detects basal mitochondrial respiration, ATP production-coupled respiration and other respiration. By stratifying these results by genotype, I will see if the genotype of a hepatocyte has an effect on the mitochondrial function in these cell types.
Additionally, I will be genotyping patients who are receiving an MRI for NAFLD. I will analyze their biochemical data, as well as MRI results for liver fat content and stiffness, stratified by genotype.
Overall I hope to find the phenotypic significance of this SNP, as it could provide a genetic marker for these prevalent diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406360
Name
Zhang Hannah
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Gly482Ser single nucleotide polymorphism in hepatocyte function through induced pluripotent stem cells and human samples
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diabetes; Hepatocyte; Ipsc; Metabolism; Mitochondria; Nafld; Polymorphism; Stem Cell
Abstract
Diabetes and nonalcoholic fatty liver disease (NAFLD) are growing metabolic problems in our society today. PGC-1a is a protein expressed in liver cells, and is involved in mitochondrial biogenesis, fatty acid oxidation and increased gluconeogenesis. It is found to be upregulated in mouse models as well as patients with diabetes.
The single nucleotide polymorphism (SNP) Gly482Ser is known to exist on PGC-1a, and we wish to investigate its effect on hepatocyte mitochondrial function. The glycine SNP is “normal” in humans, and the variant serine SNP is found in about 10% of people. I wish to investigate the role of this SNP in hepatocyte metabolic function.
I will be genotyping induced pluripotent stem cells (iPSCs), and using CRISPR technology to create lines of all three genotypes (gly/gly, ser/gly, ser/ser). Then we will differentiate the cells into hepatocyte-like cells, and validate that the cells function like hepatocytes. I will need to optimize this process to ensure the cells have the proper characteristics.
Once I have shown the cells have been correctly differentiated, i will test their mitochondrial function using a Seahorse XF Cell Mito Stress Test Kit. This test detects basal mitochondrial respiration, ATP production-coupled respiration and other respiration. By stratifying these results by genotype, I will see if the genotype of a hepatocyte has an effect on the mitochondrial function in these cell types.
Additionally, I will be genotyping patients who are receiving an MRI for NAFLD. I will analyze their biochemical data, as well as MRI results for liver fat content and stiffness, stratified by genotype.
Overall I hope to find the phenotypic significance of this SNP, as it could provide a genetic marker for these prevalent diseases.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zhang, Hannah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~